CLEV 10-K & 10-Q changes, risk factors and insider trading
Concrete Leveling Systems Inc · OTC · Misc Industrial & Commercial Machinery & Equipment · CIK 1414382 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Not required for a Smaller Reporting Company.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
“Cash flows provided by financing activities were $49,986 for the year ended July 31, 2024 which compares to cash flows provided by financing activities of $44,368 for the year ended July 31, 2023. The change in cash flows provided by financing activities is due to an increase in advances from stockholders during the year ended July 31, 2024. We anticipate significant increases in cash flows provided by financing activities during the next 12 months, as we intend to raise capital through either debt or equity securities to fund our business.”see in full comparison
In its audited financial statements as of July 31,see in full comparison2024,2025, theCompanyCompany’swasauditors issued an opinionby its auditorsthat raised substantial doubt about the ability to continue as a going concernbaseddueontothe Company’sits current financial position.OurThe Company’s ability to achieve andmaintainsustain profitability and positive cash flowisdependsdependentonupontheoursuccessfulability to successfully developdevelopment andmarketmarketingourof its products andourgenerationabilityofto generatesufficient revenues.
“As of July 31, 2025, our total assets were $19,479 and our total liabilities were $641,128. As of July 31, 2024, our total assets were $18,666 and our total liabilities were $578,925.”see in full comparison
“As of July 31, 2024, our total assets were $18,666 and our total liabilities were $578,925. As of July 31, 2023, our total assets were $25,444 and our total liabilities were $519,718.”see in full comparison
“As of July 31, 2025, we had cash or cash equivalents of $824. As of July 31, 2024, we had cash or cash equivalents of $887.”see in full comparison
“As of July 31, 2024, we had cash or cash equivalents of $887. As of July 31, 2023, we had cash or cash equivalents of $682.”see in full comparison
Full comparison: every changed paragraph (7)
In its audited financial statements as of July 31, 2024,2025, the CompanyCompany’s wasauditors issued an opinion by its auditors that raised substantial doubt about the ability to continue as a going concern baseddue onto the Company’sits current financial position. OurThe Company’s ability to achieve and maintainsustain profitability and positive cash flow isdepends dependenton uponthe oursuccessful ability to successfully developdevelopment and marketmarketing ourof its products and ourgeneration abilityof to generatesufficient revenues.
As of July 31, 2025, we had cash or cash equivalents of $824. As of July 31, 2024, we had cash or cash equivalents of $887.
As of July 31, 2024, we had cash or cash equivalents of $887. As of July 31, 2023, we had cash or cash equivalents of $682.
Net cash used in operating activities for the year ended July 31, 20242025 was $49,781.$63. This compares to net cash usedprovided inby operating activities of $44,433$205 for the year ended July 31, 2023.2024. This change is primarily due to an increase in net losses during the year ended July 31, 2024.2025.
As of July 31, 2025, our total assets were $19,479 and our total liabilities were $641,128. As of July 31, 2024, our total assets were $18,666 and our total liabilities were $578,925.
Cash flows provided by financing activities were $49,986 for the year ended July 31, 2024 which compares to cash flows provided by financing activities of $44,368 for the year ended July 31, 2023. The change in cash flows provided by financing activities is due to an increase in advances from stockholders during the year ended July 31, 2024. We anticipate significant increases in cash flows provided by financing activities during the next 12 months, as we intend to raise capital through either debt or equity securities to fund our business.
As of July 31, 2024, our total assets were $18,666 and our total liabilities were $578,925. As of July 31, 2023, our total assets were $25,444 and our total liabilities were $519,718.
What changed in the latest 10-Q
Risk Factors
We are not required to provide this information as we are a Smaller Reporting Company.
No wording changes found in this section.
Full comparison: every changed paragraph (0)
Management's Discussion & Analysis (MD&A)
Largest changes
For the Three andsee in full comparisonSixNine Months EndedJanuaryApril31,30, 2026 Compared to the Three andSixNine Months EndedJanuaryApril31,30, 2025
“Cash flows provided by financing activities were $0 for the nine months ended April 30, 2026 which compares to cash flows provided by financing activities of $43,729 for the nine months ended April 30, 2025. The change in cash flows provided by financing activities is due to fewer advances from stockholders during the nine months ended April 30, 2026.”see in full comparison
Cost of sales for thesee in full comparisonsixnine months endedJanuaryApril31,30, 2026 was$1,061,$1,258, which compares to cost of sales of$69$124 for thesixnine months endedJanuaryApril31,30, 2025. Our costs of sales increased during thesixnine months endedJanuaryApril31,30, 2026 due to a change in product mix from services to parts and unit. Gross profit percentage increased due to the unit sold being carried at zero cost.
The Company generatedsee in full comparison$55,150$55,940 in revenue for thesixnine months endedJanuaryApril31,30, 2026, which compares to revenue of$308$483 for thesixnine months endedJanuaryApril31,30, 2025. Our revenues increased during thesixnine months endedJanuaryApril31,30, 2026, due tohigherthe sale of a leveling unitandinpartsAugustsales.2025.
Net cash provided by operating activities for thesee in full comparisonsixnine months endedJanuaryApril31,30, 2026 was$20,059.$1,431. This compares to net cash used in operating activities of$210$43,873 for thesixnine months endedJanuaryApril31,30, 2025. We experienced ahigherlower operatingincomeloss during thesixnine months endedJanuaryApril31,30, 2026.
Cost of sales for the three months endedsee in full comparisonJanuaryApril31,30, 2026 was$12,$197, which compares to cost of sales of$10$55 for the three months endedJanuaryApril31,30, 2025. Our costs of sales increased during the three months endedJanuaryApril31,30, 2026 due toahigherchangepartsin product mix from services to parts.sales.
Full comparison: every changed paragraph (17)
The following discussion and analysis was prepared to supplement information contained in the accompanying financial statements and is intended to provide certain details regarding the Company’s financial condition as of JanuaryApril 31,30, 2026, and the results of operations for the three and sixnine months ended JanuaryApril 31,30, 2026. It should be read in conjunction with the unaudited financial statements and notes thereto contained in this report as well as the audited financial statements included in the Company’s Annual Report on Form 10-K for the fiscal years ended July 31, 2025 and 2024.
Also, upon the regulatory review, the finalization of closing documentation, and the completion of financing arrangements for the project, the Company’s President will cancel all shares of common stock held (879,167 shares as of JanuaryApril 31,30, 20252026), the Company’s Chief Executive Officer will cancel all but 550,000 shares of common stock held (2,951,667 shares as of JanuaryApril 31,30, 20252026), subject to an 18-month non-dilution right in order to maintain an ownership percentage of 4.99%, and the Company’s Secretary will cancel all but 45,000 shares of common stock held (185,000 shares as of JanuaryApril 31,30, 20252026). Prior to the August 13, 2018 amendment to the agreement with Jericho, the Chief Executive Officer would cancel all but 523,000 shares of her common stock, subject to an 18-month non-dilution right in order to maintain an ownership percentage of 4.99%. The amendment provided that the Chief Executive Officer would retain an additional 27,000 shares of common stock and the non-dilution right was eliminated.
For the Three and SixNine Months Ended JanuaryApril 31,30, 2026 Compared to the Three and SixNine Months Ended JanuaryApril 31,30, 2025
The Company generated $150$790 in revenue for the three months ended JanuaryApril 31,30, 2026, which compares to revenue of $125$175 for the three months ended JanuaryApril 31,30, 2025. Our revenues increased during the three months ended JanuaryApril 31,30, 2026, due to higher parts sales.
The Company generated $55,150$55,940 in revenue for the sixnine months ended JanuaryApril 31,30, 2026, which compares to revenue of $308$483 for the sixnine months ended JanuaryApril 31,30, 2025. Our revenues increased during the sixnine months ended JanuaryApril 31,30, 2026, due to higherthe sale of a leveling unit andin partsAugust sales.2025.
Cost of sales for the three months ended JanuaryApril 31,30, 2026 was $12,$197, which compares to cost of sales of $10$55 for the three months ended JanuaryApril 31,30, 2025. Our costs of sales increased during the three months ended JanuaryApril 31,30, 2026 due to ahigher changeparts in product mix from services to parts.sales.
Cost of sales for the sixnine months ended JanuaryApril 31,30, 2026 was $1,061,$1,258, which compares to cost of sales of $69$124 for the sixnine months ended JanuaryApril 31,30, 2025. Our costs of sales increased during the sixnine months ended JanuaryApril 31,30, 2026 due to a change in product mix from services to parts and unit. Gross profit percentage increased due to the unit sold being carried at zero cost.
Operating expenses, which consisted of selling, general, and administrative expenses, and legal and professional fees for the three months ended JanuaryApril 31,30, 2026, were $13,704.$17,586. This compares with operating expenses for the three months ended JanuaryApril 31,30, 2025 of $10,227.$9,282. Our operating expenses increased during the three months ended JanuaryApril 31,30, 2026 primarily due to increases in our professional fees resulting from higher accounting and auditing fees.
Operating expenses, which consisted of selling, general, and administrative expenses, and legal and professional fees for the sixnine months ended JanuaryApril 31,30, 2026, were $48,724.$66,310. This compares with operating expenses for the sixnine months ended JanuaryApril 31,30, 2025 of $32,559.$41,840. Our operating expenses increased during the sixnine months ended JanuaryApril 31,30, 2026 primarily due to an overall increase in our professional fees resulting from higher accounting and auditing fees, as well as commissions paid.
As a result of the foregoing, we had a net loss of $15,817$19,244 for the three months ended JanuaryApril 31,30, 2026. This compares with a net loss of $12,696$11,709 for the three months ended JanuaryApril 31,30, 2025.
As a result of the foregoing, we had a net incomeloss of $862$18,382 for the sixnine months ended JanuaryApril 31,30, 2026. This compares with a net loss of $37,499$49,208 for the sixnine months ended JanuaryApril 31,30, 2025. The increaseddecreased incomeloss was due primarily to higher unit sales.
As of JanuaryApril 31,30, 2026, we had cash of $19,749.$1,121. As of July 31, 2025, we had cash of $824.
Net cash provided by operating activities for the sixnine months ended JanuaryApril 31,30, 2026 was $20,059.$1,431. This compares to net cash used in operating activities of $210$43,873 for the sixnine months ended JanuaryApril 31,30, 2025. We experienced a higherlower operating incomeloss during the sixnine months ended JanuaryApril 31,30, 2026.
Cash flows used in investing activities were $1,134 for the sixnine months ended JanuaryApril 31,30, 2026 which compares to cash flows used in investing activities of $-0- for the sixnine months ended JanuaryApril 31,30, 2025. The change in cash flows used in investing activities is due to purchases of equipment during the sixnine months ended JanuaryApril 31,30, 2026.
Cash flows provided by financing activities were $0 for the nine months ended April 30, 2026 which compares to cash flows provided by financing activities of $43,729 for the nine months ended April 30, 2025. The change in cash flows provided by financing activities is due to fewer advances from stockholders during the nine months ended April 30, 2026.
As of JanuaryApril 31,30, 2026, our total assets were $41,943$22,819 and our total liabilities were $662,730.$662,850. As of July 31, 2025, our total assets were $19,479 and our total liabilities were $641,128.
The Company was formed on August 28, 2007 and was in the development stage through July 31, 2009. The year ended July 31, 2010 was the first year during which it was considered an operating company. The Company has sustained substantial operating losses since its inception. In addition, the Company has used substantial amounts of working capital in its operations. Further, at JanuaryApril 31,30, 2026, our liabilities exceed our assets by $621,820.$640,964.
CLEV insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding CLEV (13F)
None of the 59 investors we track reported a position in their latest 13F.